by Usha Govindarajulu | Sep 14, 2022 | Biostatistics, Blog, COVID-19, Healtcare
September 14, 2022 According to a recent article in Nature Communications, regular rapid testing provided two-fold benefits: identifying infectious individuals and providing positive tests sufficiently early during infection that treatment with antivirals can...
by Usha Govindarajulu | Oct 14, 2021 | Biostatistics, Blog, Healtcare, Usha Govindarajulu
Antivirals EUA October 13, 2021 In recent news, Merck and Ridgeback has been hailing an oral anti-viral drug against Sars-CoV-2 that can cut the hospitalization and death rates in half according to their news posted on Oct 1, 2021 on their website. Apparently, the...
